Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poison Control Centers | 7 | 2023 | 14 | 2.970 |
Why?
|
| Cannabis | 3 | 2023 | 147 | 2.110 |
Why?
|
| Poisons | 2 | 2023 | 2 | 1.800 |
Why?
|
| Hallucinogens | 2 | 2023 | 60 | 1.680 |
Why?
|
| Poisoning | 8 | 2021 | 31 | 1.360 |
Why?
|
| Lead Poisoning | 3 | 2019 | 13 | 0.950 |
Why?
|
| Emergency Service, Hospital | 5 | 2022 | 538 | 0.920 |
Why?
|
| Pharmacogenetics | 1 | 2022 | 55 | 0.870 |
Why?
|
| Methylene Blue | 1 | 2021 | 12 | 0.820 |
Why?
|
| Methemoglobinemia | 1 | 2021 | 7 | 0.820 |
Why?
|
| Manufactured Materials | 1 | 2021 | 2 | 0.810 |
Why?
|
| Mitragyna | 1 | 2021 | 9 | 0.800 |
Why?
|
| Antidotes | 3 | 2021 | 33 | 0.800 |
Why?
|
| Commerce | 1 | 2021 | 47 | 0.780 |
Why?
|
| Emergencies | 4 | 2010 | 92 | 0.780 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 76 | 0.730 |
Why?
|
| Occupational Exposure | 1 | 2021 | 129 | 0.710 |
Why?
|
| Toxicology | 2 | 2010 | 31 | 0.680 |
Why?
|
| Foreign Bodies | 1 | 2019 | 64 | 0.660 |
Why?
|
| Child | 22 | 2022 | 7337 | 0.630 |
Why?
|
| Psychotropic Drugs | 3 | 2022 | 82 | 0.610 |
Why?
|
| Drug Utilization | 2 | 2015 | 74 | 0.550 |
Why?
|
| Humans | 41 | 2023 | 54246 | 0.540 |
Why?
|
| Adolescent | 13 | 2022 | 6885 | 0.530 |
Why?
|
| Medical Order Entry Systems | 1 | 2015 | 13 | 0.520 |
Why?
|
| Vancomycin | 1 | 2015 | 88 | 0.490 |
Why?
|
| United States | 9 | 2022 | 5200 | 0.480 |
Why?
|
| Guideline Adherence | 1 | 2015 | 147 | 0.460 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1998 | 31 | 0.450 |
Why?
|
| Serotonin Syndrome | 1 | 2012 | 7 | 0.440 |
Why?
|
| Child, Preschool | 13 | 2022 | 4146 | 0.420 |
Why?
|
| Adult | 11 | 2022 | 14182 | 0.400 |
Why?
|
| Pediatrics | 2 | 2015 | 323 | 0.400 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 64 | 0.380 |
Why?
|
| Safety Management | 1 | 2010 | 49 | 0.380 |
Why?
|
| Chelation Therapy | 3 | 2019 | 6 | 0.380 |
Why?
|
| Specialization | 1 | 2010 | 46 | 0.380 |
Why?
|
| Adrenergic Agonists | 1 | 2010 | 7 | 0.370 |
Why?
|
| Reproduction | 2 | 2007 | 56 | 0.360 |
Why?
|
| Professional Role | 1 | 2010 | 88 | 0.360 |
Why?
|
| Self Administration | 1 | 2010 | 99 | 0.360 |
Why?
|
| Male | 19 | 2021 | 27312 | 0.350 |
Why?
|
| Epinephrine | 1 | 2010 | 97 | 0.350 |
Why?
|
| Female | 19 | 2021 | 28418 | 0.350 |
Why?
|
| Seizures | 3 | 2003 | 208 | 0.350 |
Why?
|
| Antivenins | 2 | 2006 | 12 | 0.340 |
Why?
|
| Snake Bites | 2 | 2006 | 19 | 0.330 |
Why?
|
| Patient Care Team | 1 | 2010 | 273 | 0.330 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2007 | 2 | 0.310 |
Why?
|
| Nonprescription Drugs | 2 | 2021 | 42 | 0.310 |
Why?
|
| Infant | 10 | 2019 | 3817 | 0.310 |
Why?
|
| Embryonic Development | 1 | 2007 | 17 | 0.310 |
Why?
|
| Hydroxyurea | 1 | 2007 | 29 | 0.300 |
Why?
|
| Ibuprofen | 1 | 2007 | 28 | 0.300 |
Why?
|
| Acetaminophen | 2 | 2007 | 349 | 0.290 |
Why?
|
| Fever | 1 | 2007 | 129 | 0.280 |
Why?
|
| Databases, Factual | 2 | 2022 | 684 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2022 | 6432 | 0.270 |
Why?
|
| Drug Overdose | 4 | 2021 | 154 | 0.270 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2007 | 140 | 0.270 |
Why?
|
| Snake Venoms | 1 | 2005 | 4 | 0.270 |
Why?
|
| Antipsychotic Agents | 2 | 2005 | 247 | 0.260 |
Why?
|
| Young Adult | 4 | 2021 | 4308 | 0.260 |
Why?
|
| Succimer | 2 | 1994 | 4 | 0.250 |
Why?
|
| Iron | 1 | 2006 | 158 | 0.250 |
Why?
|
| Suicide, Attempted | 3 | 2021 | 73 | 0.250 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2004 | 8 | 0.250 |
Why?
|
| Analgesics | 2 | 2022 | 106 | 0.240 |
Why?
|
| Parents | 1 | 2007 | 344 | 0.240 |
Why?
|
| Psychomotor Agitation | 1 | 2004 | 53 | 0.240 |
Why?
|
| Violence | 1 | 2004 | 82 | 0.230 |
Why?
|
| Child Behavior Disorders | 1 | 2004 | 87 | 0.230 |
Why?
|
| Psychotic Disorders | 1 | 2004 | 144 | 0.220 |
Why?
|
| Middle Aged | 7 | 2021 | 13070 | 0.220 |
Why?
|
| Aged | 5 | 2021 | 10041 | 0.210 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 96 | 0.210 |
Why?
|
| Arrhythmias, Cardiac | 3 | 1998 | 98 | 0.200 |
Why?
|
| Diphenhydramine | 1 | 2021 | 20 | 0.200 |
Why?
|
| Mood Disorders | 1 | 2001 | 63 | 0.190 |
Why?
|
| Conscious Sedation | 2 | 1997 | 28 | 0.190 |
Why?
|
| Forecasting | 1 | 2021 | 161 | 0.190 |
Why?
|
| Cholinergic Antagonists | 2 | 2012 | 6 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 231 | 0.180 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1999 | 2 | 0.180 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1999 | 17 | 0.180 |
Why?
|
| Sodium Bicarbonate | 1 | 1998 | 9 | 0.170 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 50 | 0.170 |
Why?
|
| Eating | 1 | 2019 | 155 | 0.160 |
Why?
|
| Fluid Therapy | 1 | 1998 | 87 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 492 | 0.160 |
Why?
|
| Dehydration | 1 | 1998 | 80 | 0.160 |
Why?
|
| Depression | 1 | 2002 | 594 | 0.150 |
Why?
|
| Environmental Exposure | 2 | 2010 | 205 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2001 | 451 | 0.140 |
Why?
|
| Wound Healing | 1 | 1997 | 228 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1679 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 3429 | 0.130 |
Why?
|
| Electrocardiography | 1 | 1997 | 290 | 0.130 |
Why?
|
| Pain Management | 1 | 1996 | 155 | 0.130 |
Why?
|
| Penicillamine | 1 | 1994 | 6 | 0.130 |
Why?
|
| Miosis | 1 | 2014 | 5 | 0.130 |
Why?
|
| Nystagmus, Pathologic | 1 | 2014 | 7 | 0.130 |
Why?
|
| Drug Resistance, Microbial | 1 | 2015 | 51 | 0.130 |
Why?
|
| Mydriasis | 1 | 2014 | 4 | 0.130 |
Why?
|
| Detergents | 1 | 2014 | 17 | 0.130 |
Why?
|
| Quality Control | 1 | 2015 | 101 | 0.130 |
Why?
|
| Esophagus | 1 | 2014 | 79 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 321 | 0.120 |
Why?
|
| Endoscopy | 1 | 2014 | 131 | 0.120 |
Why?
|
| Methylphenidate | 2 | 2005 | 94 | 0.110 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2012 | 3 | 0.110 |
Why?
|
| Malignant Hyperthermia | 1 | 2012 | 10 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 1998 | 475 | 0.110 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2012 | 11 | 0.110 |
Why?
|
| Shock | 1 | 2012 | 37 | 0.100 |
Why?
|
| Developmental Disabilities | 2 | 2005 | 126 | 0.100 |
Why?
|
| Serotonin | 1 | 2012 | 159 | 0.100 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2010 | 2 | 0.100 |
Why?
|
| Electronic Prescribing | 1 | 2010 | 4 | 0.100 |
Why?
|
| Hospital Communication Systems | 1 | 2010 | 6 | 0.100 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 6 | 0.100 |
Why?
|
| Aviation | 1 | 2010 | 7 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 426 | 0.100 |
Why?
|
| Medication Errors | 1 | 2010 | 26 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2005 | 255 | 0.100 |
Why?
|
| Social Responsibility | 1 | 2010 | 31 | 0.100 |
Why?
|
| Medical Errors | 1 | 2010 | 34 | 0.100 |
Why?
|
| Pregnancy | 3 | 2007 | 2620 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2006 | 459 | 0.100 |
Why?
|
| Xenobiotics | 1 | 2010 | 27 | 0.090 |
Why?
|
| Communication Barriers | 1 | 2010 | 37 | 0.090 |
Why?
|
| Drug Industry | 1 | 2010 | 40 | 0.090 |
Why?
|
| Patient Care | 1 | 2010 | 61 | 0.090 |
Why?
|
| Health Resources | 1 | 2010 | 80 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2010 | 97 | 0.090 |
Why?
|
| Leadership | 1 | 2010 | 114 | 0.090 |
Why?
|
| Camphor | 2 | 2003 | 2 | 0.090 |
Why?
|
| Anaphylaxis | 1 | 2010 | 71 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2010 | 205 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1136 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 671 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2005 | 2907 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 13 | 0.080 |
Why?
|
| Chemical Warfare Agents | 1 | 2007 | 1 | 0.080 |
Why?
|
| Chemical Terrorism | 1 | 2007 | 1 | 0.080 |
Why?
|
| Methanol | 1 | 2006 | 7 | 0.070 |
Why?
|
| Ethylene Glycol | 1 | 2006 | 5 | 0.070 |
Why?
|
| Cohort Studies | 3 | 1997 | 1543 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2006 | 21 | 0.070 |
Why?
|
| Crotalid Venoms | 1 | 2006 | 12 | 0.070 |
Why?
|
| Syringes | 1 | 2006 | 14 | 0.070 |
Why?
|
| Immunoglobulin Fragments | 1 | 2006 | 19 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 25 | 0.070 |
Why?
|
| Deferoxamine | 1 | 2006 | 12 | 0.070 |
Why?
|
| Siderophores | 1 | 2006 | 11 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 194 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2006 | 118 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 231 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 401 | 0.070 |
Why?
|
| Growth and Development | 1 | 2005 | 16 | 0.070 |
Why?
|
| Vitamins | 1 | 2006 | 72 | 0.070 |
Why?
|
| Amphetamine | 1 | 2005 | 42 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2006 | 110 | 0.070 |
Why?
|
| Self Care | 1 | 2007 | 143 | 0.070 |
Why?
|
| Nervous System | 1 | 2005 | 34 | 0.070 |
Why?
|
| Triage | 1 | 2006 | 76 | 0.070 |
Why?
|
| Infertility | 1 | 2005 | 20 | 0.070 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2005 | 125 | 0.060 |
Why?
|
| Health Personnel | 1 | 2007 | 246 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 310 | 0.060 |
Why?
|
| Ginkgo biloba | 1 | 2003 | 8 | 0.060 |
Why?
|
| GABA Antagonists | 1 | 2003 | 10 | 0.060 |
Why?
|
| Phenytoin | 1 | 2003 | 23 | 0.060 |
Why?
|
| Isoniazid | 1 | 2003 | 30 | 0.060 |
Why?
|
| Insecticides | 1 | 2003 | 19 | 0.060 |
Why?
|
| Seeds | 1 | 2003 | 31 | 0.060 |
Why?
|
| Tachycardia | 1 | 2003 | 32 | 0.060 |
Why?
|
| Methamphetamine | 1 | 2005 | 233 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2003 | 206 | 0.060 |
Why?
|
| Time Factors | 2 | 2021 | 3212 | 0.050 |
Why?
|
| Pyridines | 1 | 2003 | 137 | 0.050 |
Why?
|
| Cocaine | 1 | 2003 | 184 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 384 | 0.050 |
Why?
|
| Animals | 4 | 2007 | 14385 | 0.050 |
Why?
|
| Age Factors | 2 | 2005 | 1195 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 1361 | 0.050 |
Why?
|
| Prospective Studies | 2 | 1997 | 2604 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 187 | 0.050 |
Why?
|
| Brain Damage, Chronic | 1 | 1999 | 13 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1225 | 0.040 |
Why?
|
| Methacrylates | 1 | 1998 | 8 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 1998 | 6 | 0.040 |
Why?
|
| Consumer Product Safety | 1 | 1998 | 22 | 0.040 |
Why?
|
| Cosmetics | 1 | 1998 | 5 | 0.040 |
Why?
|
| Mutation | 1 | 2005 | 1501 | 0.040 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 1 | 0.040 |
Why?
|
| Rehydration Solutions | 1 | 1998 | 11 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 1998 | 51 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 1999 | 79 | 0.040 |
Why?
|
| Vomiting | 1 | 1998 | 73 | 0.040 |
Why?
|
| Diarrhea | 1 | 1998 | 90 | 0.040 |
Why?
|
| Prenatal Care | 1 | 1999 | 116 | 0.040 |
Why?
|
| Cyanoacrylates | 1 | 1997 | 8 | 0.040 |
Why?
|
| Tissue Adhesives | 1 | 1997 | 15 | 0.040 |
Why?
|
| Fetus | 1 | 1999 | 227 | 0.040 |
Why?
|
| Hypotension | 1 | 1998 | 67 | 0.040 |
Why?
|
| Patient Selection | 1 | 1999 | 286 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1997 | 232 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 318 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 1996 | 19 | 0.040 |
Why?
|
| Acute Disease | 1 | 1997 | 403 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 74 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1996 | 246 | 0.030 |
Why?
|
| Dextromethorphan | 1 | 2014 | 20 | 0.030 |
Why?
|
| Clonidine | 1 | 2014 | 24 | 0.030 |
Why?
|
| Amphetamines | 1 | 2014 | 28 | 0.030 |
Why?
|
| ROC Curve | 1 | 1995 | 259 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 1996 | 203 | 0.030 |
Why?
|
| Anxiety | 1 | 1996 | 278 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1994 | 85 | 0.030 |
Why?
|
| Diphenoxylate | 1 | 1993 | 1 | 0.030 |
Why?
|
| Lead | 1 | 1994 | 32 | 0.030 |
Why?
|
| Benzocaine | 1 | 1993 | 5 | 0.030 |
Why?
|
| Atropine | 1 | 1993 | 31 | 0.030 |
Why?
|
| Salicylates | 1 | 1993 | 10 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 1993 | 36 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1993 | 128 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 1995 | 271 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 923 | 0.030 |
Why?
|
| Imidazoles | 1 | 1993 | 142 | 0.030 |
Why?
|
| Logistic Models | 1 | 1995 | 990 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 1048 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 501 | 0.020 |
Why?
|
| Species Specificity | 1 | 2005 | 205 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2005 | 374 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 765 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1994 | 5604 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 469 | 0.010 |
Why?
|